Virtual Visitation in Intensive Care Unit Study

NCT ID: NCT04962204

Last Updated: 2021-10-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-06

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to identify the efficacy of virtual visitation in Intensive Care Unit on patients and their caregivers during COVID-19 Pandemic.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After being informed about the study, all patients who meet the eligibility requirements will be randomized in a 1:1 ratio to intervention group (Virtual visitation once a day) or Control group (Phone interviews once a day).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critically Ill Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Interventional group Control group
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual visitation group

Virtual visits between patients-caregivers and virtual interviews between physicians-caregivers for 15minutes once a day

Group Type ACTIVE_COMPARATOR

Virtual meeting between patients/physicians and caregiver

Intervention Type BEHAVIORAL

Virtual visits between patients-caregivers and virtual interviews between physicians-caregivers for 15minutes once a day

Control group

Phone interview between physicians-caregivers once a day

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual meeting between patients/physicians and caregiver

Virtual visits between patients-caregivers and virtual interviews between physicians-caregivers for 15minutes once a day

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are expected to stay in the intensive care unit for more than 48 hours
* Patients with a RASS score of -2 or higher

Exclusion Criteria

* Patients who discharge or die within 48 hours of admission to ICU
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Seung-Young Oh

Clinical Assistant Profeessor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Hospital

Seoul, Jongno-gu, South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Seung-Young Oh

Role: CONTACT

+82-2-2072-3538

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Seoul National University Hospital

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Woo HY, Oh SY, Lim L, Im H, Lee H, Ha EJ, Ryu HG. Efficacy of Virtual Visitation in ICU During COVID-19 Pandemic: The ICU Visits Randomized Controlled Trial. Crit Care Med. 2024 Dec 1;52(12):e593-e603. doi: 10.1097/CCM.0000000000006429. Epub 2024 Sep 16.

Reference Type DERIVED
PMID: 39283178 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2105-188-1224

Identifier Type: -

Identifier Source: org_study_id